BSEBoard Meeting3d ago · 4 Nov 2026, 02:27 pm

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve to consider and approve, inter alia, Unaudited Financial Result (Standalone) for the Second quarter and half year ended on September 30th, 2026

Kimia Biosciences Ltd · 530313

✦ AI SummaryResults

Kimia Biosciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve the Unaudited Financial Results (Standalone) for the Second quarter and Half year ended on September 30th, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI (LODR) Regulations, 2015 -Intimation Of Meeting Of Board Of Directors.

Attachments (1)

📄

19ac96a5-0d9c-499e-b514-e53d24feb64f.pdf

pdf

Download →
View document text
To Date: 04/11/2026 Department of Corporate Affairs- Listing, BSE Limited, Phiroz Jee Jeebhoy Towers, Dalal Street, Fort Mumbai-400001. Scrip Code: 530313 [KIMIABL] Sub: Regulation 29 of SEBI (LODR) Regulations, 2015 –Intimation of Meeting of Board of Directors. Dear Sir/Madam Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Friday, November 13, 2026, inter alia, to consider & approve the Un-Audited Financial Results (Standalone) for the Second quarter and Half year ended on September 30th, 2026. Further, In terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the Equity Shares of the Company by Designated Persons (and their immediate relatives) has already been closed w.e.f. 1st of October, 2026 up to the completion of 48 hours after the declaration of unaudited Financial Results for the Second quarter and half year ended on 30th September 2026 to the Stock Exchange. This is for your information and records. Thanking you, For Kimia Biosciences Limited Abhishek Kumar Pandey Company Secretary & Compliance Officer Membership No.: F12457 Place- Delhi KIMIA BIOSCIENCES LIMITED Regd. Office/Works Corporate Office Village Bhondsi, Damdama Lake Road, 974,9" Floor, Aggarwal Millennium Tower-II Gurugram, Haryana-122102 Netaji Subhash Place, Pitampura, New Delhi-110034, INDIA Tel.: +91 9654746544, 9654206544 Tel.: +91 11 47063600, 470630601 compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120